Clinical Colorectal Cancer Gastroenterology
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study
The publisher did not provide an abstract — full text is available via the link below.